News
Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...
The Canadian Press on MSN4d
Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...
Health Canada has approved Ozempic for use by Type 2 diabetes patients to reduce the risk of further kidney damage.
(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney ...
Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...
Stocktwits on MSN4d
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
Danish drugmaker Novo Nordisk (NVO) on Tuesday said that its blockbuster drug Ozempic is now approved in Canada to reduce the ...
Health Canada has approved Ozempic as treatment to reduce kidney deterioration in people with Type 2 diabetes.
InvestorsHub on MSN4d
Novo Nordisk’s Ozempic Secures Canadian Approval for Kidney Disease Use
Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting approval for use in patients with chronic kidney disease. The new indication ...
The Canadian Press on MSN4d
Quebec City using artificial intelligence to manage traffic, reduce congestion
According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback